This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Gangrene, not elsewhere classified
R18_GANGRENE_NOT_ELSEW_CLASSIFIED
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
264 |
4. Check minimum number of eventsNone |
264 |
5. Include endpointsNone |
264 |
6. Filter based on genotype QC (FinnGen only) |
264 |
Control definitions (FinnGen only)
- Control exclude
- R18_SYMPTOMS_SIGNS_INVOLVI_CIRCULATO_RESPI_SYSTEMS
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF4
- Parent code in ICD-10
- R0
- Name in latin
- Gangraena non alibi classificata
Similar endpoints
↥List of similar endpoints to
Gangrene, not elsewhere classified
based on the number of shared cases.
Similar with more cases:
- Symptoms and signs involving the circulatory and respiratory systems
- Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 264 | 101 | 163 |
| Unadjusted period prevalence (%) | 0.06 | 0.03 | 0.07 |
| Median age at first event (years) | 71.84 | 72.13 | 71.66 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 237
- Matched controls
- 2370
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
R02
ICD-10 Finland
Gangrene, not elsewhere classified
+∞
323.0
236
*
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
29.0
105.0
163
167
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
40.6
101.5
132
71
NHQ40
NOMESCO Finland
Amputation of toe
109.7
100.3
105
17
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
44.5
92.1
115
49
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
29.4
91.4
132
97
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
26.1
57.5
82
47
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
38.4
55.9
71
26
PF1AT
NOMESCO Finland
Intravascular dilatation of arteries of knee, lower leg and ankle (PTA)
72.4
53.7
60
11
PD4CG
NOMESCO Finland
Extensive MRI examination of abdominal aortta and vasculature of lower extremities with high intensity magnet
58.0
52.6
61
14
E11.5
ICD-10 Finland
Type 2 diabetes mellitus, with peripheral circulatory complications
41.4
49.9
62
20
XQ858
NOMESCO Finland
Oxygen partial pressure measurement
122.9
46.8
49
5
NHQ30
NOMESCO Finland
Amputation of foot, transmetatarsal
89.9
46.1
50
7
PE1AT
NOMESCO Finland
Femoral artery PTA
69.9
44.5
50
9
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
15.5
44.4
77
71
NFQ20
NOMESCO Finland
Amputation of femur
61.3
42.7
49
10
ZXD05
NOMESCO Finland
Urgent procedure
6.6
39.9
148
476
B01AC04
ATC
clopidogrel; oral
7.4
38.2
110
247
PF1BT
NOMESCO Finland
Extensive PTA of arteries of knee, lower leg and ankle
79.7
36.3
40
6
C03CA01
ATC
furosemide; systemic
6.0
36.2
156
579
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
9.3
35.8
82
127
S97
ICPC
Chronic ulcer skin
13.0
35.0
65
67
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
10.3
34.4
73
98
Z3231
NOMESCO Finland
Registered nurse
5.8
33.6
128
398
WX213
NOMESCO Finland
Lower leg blockade
64.2
33.4
38
7
PD4DE
NOMESCO Finland
Lower extremity artery ultrasound examination with Doppler method
32.5
32.9
43
16
R07.4
ICD-10 Finland
Chest pain, unspecified
10.1
32.8
70
94
R4110
NOMESCO Finland
Physiotherapy
5.6
31.3
118
355
Z3226
NOMESCO Finland
Physiotherapist
6.4
31.1
98
236
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
68.0
31.1
35
6
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
9.0
31.0
71
107
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
6.4
30.2
93
216
J01FF01
ATC
clindamycin; systemic
5.4
30.2
119
373
A10AE04
ATC
insulin glargine; parenteral
8.3
29.7
72
118
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
6.0
29.7
99
253
A49.9
ICD-10 Finland
Bacterial infection, unspecified
7.3
29.5
79
151
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
8.6
29.3
69
108
R06.0
ICD-10 Finland
Dyspnoea
8.3
28.7
69
111
WX892
NOMESCO Finland
Monitored bed care
9.6
27.3
59
79
XF400
NOMESCO Finland
ECG with 12 standard connections
5.9
27.1
89
219
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
6.0
26.3
84
199
SPAT1148
SPAT
Treatment of chronic ulcer or burn
6.0
26.3
83
194
PD4AC
NOMESCO Finland
Arterigography of lower extremity with X-ray
24.7
25.7
36
17
103
Kela drug reimbursment
Diabetes, insulin-treated
4.5
25.7
132
517
PD4CC
NOMESCO Finland
Very extensive arterigography of lower extremity with X-ray
44.2
25.6
31
8
J01MA12
ATC
levofloxacin; systemic
5.2
25.4
95
269
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
25.4
148
653
TPH04
NOMESCO Finland
Cathetrisation of vein
5.3
25.3
93
258
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
23.3
25.2
36
18
Z2221
NOMESCO Finland
Medical doctor
4.7
24.4
106
349
I702, L97
ICD-10 Finland
NA
+∞
24.4
23
*
TQW11
NOMESCO Finland
Vacuum treatment of wound
24.6
24.3
34
16
N03AX16
ATC
pregabalin; oral
5.0
24.0
94
277
NGQ20
NOMESCO Finland
Amputation of lower leg
37.9
24.0
30
9
QD6S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in foot
72.6
23.3
26
*
PEF23
NOMESCO Finland
Thrombendarterectomy of femoral artery
20.7
23.0
34
19
C07AB07
ATC
bisoprolol; oral
4.1
22.9
162
822
A11CC03
ATC
alfacalcidol; systemic
24.4
22.8
32
15
A46
ICD-10 Finland
Erysipelas
5.5
22.8
77
191
A12AA04
ATC
calcium carbonate; oral
28.4
22.4
30
12
ZXA00
NOMESCO Finland
Right side
4.2
22.2
112
414
ZXE20
NOMESCO Finland
More than three and less than five hours
5.4
22.1
76
191
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
8.6
22.1
50
71
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
9.8
22.0
46
57
ZXE00
NOMESCO Finland
One hour or less
3.9
21.7
129
553
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
10.5
21.5
43
49
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
6.1
21.4
64
136
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
11.0
21.1
41
44
XF655
NOMESCO Finland
Measurement of heart muscle perfusion with exercise
20.8
21.1
31
17
QDG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of lower limb
22.7
21.0
30
15
TK800
NOMESCO Finland
Hemodialysis
17.2
20.9
33
22
QDB99
NOMESCO Finland
Other procedure for wound of skin of lower limb
36.3
20.7
26
8
I50.9
ICD-10 Finland
Heart failure, unspecified
4.8
20.3
78
219
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
18.6
20.3
31
19
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
20.0
20.2
30
17
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
4.4
20.1
87
275
ZXE10
NOMESCO Finland
More than one and less than three hours
3.7
20.1
127
561
PFH66
NOMESCO Finland
Bypass from femoral or popliteal artery to dorsal artery of foot
80.3
20.1
22
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
5.0
19.8
72
190
J01DB01
ATC
cefalexin; oral
5.1
19.8
210
1427
PE1BT
NOMESCO Finland
Femoral artery extensive PTA
34.7
19.7
25
8
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
5.9
19.6
59
125
Z49.1
ICD-10 Finland
Extracorporeal dialysis
22.5
19.6
28
14
N02AA05
ATC
oxycodone; systemic
4.6
19.5
79
233
WX408
NOMESCO Finland
General anesthesy, balanced
4.0
19.2
97
351
N02AX02
ATC
tramadol; systemic, rectal
3.5
18.9
134
638
ZXD10
NOMESCO Finland
Scheduled procedure
3.6
18.9
128
588
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
5.5
18.8
61
141
TKC20
NOMESCO Finland
Catheterisation of bladder
6.3
18.8
53
103
J01MA02
ATC
ciprofloxacin; systemic
3.5
18.5
134
644
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.9
18.5
95
347
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
18.5
18.4
28
17
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
7.1
18.3
47
80
AB14W
NOMESCO Finland
NA
72.4
18.0
20
*
I25.1
ICD-10 Finland
Atherosclerotic heart disease
3.7
18.0
100
389
215
Kela drug reimbursment
Diabetes, non-insulin-treated
3.6
17.4
101
404
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
34.4
17.4
22
7
PD4BC
NOMESCO Finland
Extensive arterigography of lower extremity with X-ray
15.7
17.3
28
20
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
28.1
17.3
23
9
A10BB12
ATC
glimepiride; oral
5.5
17.1
54
120
M79.6
ICD-10 Finland
Pain in limb
3.5
16.9
101
411
PFP99
NOMESCO Finland
Percutaneous plastic repair of artery of lower leg
+∞
16.9
16
*
ZXA05
NOMESCO Finland
Left side
3.5
16.7
102
421
WX002
NOMESCO Finland
Sedation and analgesia
4.0
16.6
79
266
N18.0
ICD-10 Finland
End-stage renal disease
26.8
16.3
22
9
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
26.8
16.3
22
9
PD3YT
NOMESCO Finland
Pelvic artery PTA with stent
18.9
16.0
24
14
A10BB01
ATC
glibenclamide; oral
6.1
15.9
45
87
A10AE05
ATC
insulin detemir; parenteral
6.7
15.2
40
70
Z2446
NOMESCO Finland
Social worker
6.9
15.2
39
66
I70.9
ICD-10 Finland
Generalized and unspecified atherosclerosis
11.6
15.2
28
27
A06AD11
ATC
lactulose; oral
4.1
15.1
66
204
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
4.6
15.0
56
148
WX320
NOMESCO Finland
Spinalanesthesy
3.6
15.0
82
305
B03XA02
ATC
darbepoetin alfa; parenteral
15.6
14.9
24
17
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.8
14.8
44
90
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
4.4
14.8
58
161
J01CF05
ATC
flucloxacillin; systemic
10.2
14.7
29
32
V03AE01
ATC
polystyrene sulfonate; oral
18.5
14.6
22
13
R50.9
ICD-10 Finland
Fever, unspecified
4.5
14.5
56
153
TPX10
NOMESCO Finland
Implantation of vascular injection port
10.4
14.4
28
30
E11.6
ICD-10 Finland
Type 2 diabetes mellitus, with other specified complications
13.9
14.2
24
19
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
6.7
14.2
37
64
C10AA01
ATC
simvastatin; oral
2.9
14.1
147
848
I50.0
ICD-10 Finland
Congestive heart failure
5.2
13.9
45
102
L03.0
ICD-10 Finland
Cellulitis of finger and toe
6.9
13.8
35
58
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
3.1
13.7
97
432
S91.3
ICD-10 Finland
Open wound of other parts of foot
14.0
13.7
23
18
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
9.5
13.7
28
33
RJ521
NOMESCO Finland
NA
148.1
13.6
14
*
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
27.6
13.6
18
7
B01AB05
ATC
enoxaparin; parenteral
3.0
13.3
101
469
A41.9
ICD-10 Finland
Sepsis, unspecified
8.3
13.2
29
39
H3603, E113
ICD-10 Finland
NA
20.5
13.1
19
10
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
4.4
13.1
51
140
XCK10
NOMESCO Finland
Photography of fundus of eye
4.3
13.0
52
146
PEP25
NOMESCO Finland
Percutaneous plastic repair of superficial femoral artery
53.1
13.0
15
*
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
7.6
12.9
30
44
A28
ICPC
Limited function/disability NOS
3.4
12.9
72
268
L89
ICD-10 Finland
Decubitus ulcer and pressure area
12.0
12.8
23
21
NGQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of knee or lower leg
73.9
12.7
14
*
PD4CM
NOMESCO Finland
Extensive MRI examination of abdominal aorta and vasculature of lower extremities with 3 Tesla magnet
73.9
12.7
14
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
21.5
12.7
18
9
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
3.8
12.6
58
185
XY1PK
NOMESCO Finland
Perfusion spectroscopy
137.0
12.6
13
*
H3601, E113
ICD-10 Finland
NA
15.5
12.5
20
14
D64.9
ICD-10 Finland
Anaemia, unspecified
4.4
12.4
47
125
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
3.1
12.4
81
338
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
6.3
12.3
33
59
A10BA02
ATC
metformin; oral
2.8
12.3
106
527
A02BC02
ATC
pantoprazole; systemic
2.8
12.3
162
1037
XPX08
NOMESCO Finland
Intraoperative flow measurement
19.3
12.3
18
10
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
5.3
12.1
38
83
WX212
NOMESCO Finland
Femoral plexus blockade
12.7
12.1
21
18
J18.9
ICD-10 Finland
Pneumonia, unspecified
2.9
12.1
93
430
ZZA00
NOMESCO Finland
Split skin graft
6.6
12.0
31
53
B01AA03
ATC
warfarin; systemic
3.0
11.9
84
367
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
4.0
11.9
51
153
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
5.1
11.8
38
85
WX214
NOMESCO Finland
Plexus blockade at the ankle
31.9
11.8
15
5
WW200
NOMESCO Finland
Immunization
10.9
11.8
22
22
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
4.6
11.7
42
106
Z5132
NOMESCO Finland
Nursing associate professional
125.9
11.5
12
*
PFP26
NOMESCO Finland
Percutaneous plastic repair of popliteal artery
125.9
11.5
12
*
PE1YT
NOMESCO Finland
Femoral or popliteal artery PTA with stent
16.1
11.5
18
12
C10AA05
ATC
atorvastatin; oral
2.7
11.4
114
613
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
8.8
11.4
24
30
T87.4
ICD-10 Finland
Infection of amputation stump
37.0
11.4
14
*
S18
ICPC
Laceration/cut
2.7
11.4
118
645
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
12.0
11.3
20
18
QCB10
NOMESCO Finland
Major dressing of wound of skin of upper limb
12.0
11.3
20
18
WX872
NOMESCO Finland
Intensive care
6.5
11.2
29
50
QWA00
NOMESCO Finland
Repair of wound dehiscence in surgery of skin
45.6
11.0
13
*
NDQ20
NOMESCO Finland
Amputation of finger
45.6
11.0
13
*
N17.9
ICD-10 Finland
Acute renal failure, unspecified
6.3
11.0
29
51
Z49.0
ICD-10 Finland
Preparatory care for dialysis
18.9
10.9
16
9
J01DA01
ATC
[U] cefalexin; systemic
2.6
10.8
156
1015
AA1AD
NOMESCO Finland
CT of head and brain
2.9
10.7
80
359
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
7.0
10.7
26
41
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
4.7
10.7
37
90
J01MA14
ATC
moxifloxacin; systemic
4.7
10.7
37
90
N18.8
ICD-10 Finland
Other chronic renal failure
8.9
10.6
22
27
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
17.0
10.5
16
10
I20.09
ICD-10 Finland
Unstable angina
6.8
10.5
26
42
ZXE30
NOMESCO Finland
More than five and less than seven hours
5.5
10.5
31
63
E11
ICD-10 Finland
Type 2 diabetes mellitus
3.2
10.5
61
231
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
8.1
10.5
23
31
E10.5
ICD-10 Finland
Type 1 diabetes mellitus, With peripheral circulatory complications
34.2
10.4
13
*
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
4.2
10.4
41
113
Z3229
NOMESCO Finland
Other healthcare associate professional
4.3
10.3
39
104
AN1
HP
Coronary angiography
3.7
10.0
46
145
PEN23
NOMESCO Finland
Plastic repair of femoral artery
13.0
10.0
17
14
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
13.0
10.0
17
14
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
17.7
10.0
15
9
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
9.4
10.0
20
23
C01DA14
ATC
isosorbide mononitrate; oral
3.1
10.0
62
245
E10.2
ICD-10 Finland
Type 1 diabetes mellitus, With renal complications
21.1
9.9
14
7
S91.1
ICD-10 Finland
Open wound of toe(s) without damage to nail
27.4
9.9
13
5
N02BE01
ATC
paracetamol; systemic, rectal
3.1
9.9
205
1595
SPAT1149
SPAT
Suture or treatment of traumatic wound
3.4
9.9
51
177
C03DA01
ATC
spironolactone; oral
4.0
9.8
41
119
C08CA01
ATC
amlodipine; oral
2.5
9.8
114
649
M04AA01
ATC
allopurinol; systemic
3.2
9.8
57
215
PEH57
NOMESCO Finland
Bypass from femoral artery to popliteal artery below knee
12.1
9.7
17
15
N19
ICD-10 Finland
Unspecified kidney failure
7.5
9.6
22
32
J45.0
ICD-10 Finland
Predominantly allergic asthma
6.6
9.5
24
40
PG9AC
NOMESCO Finland
Arteriography with X-ray not elsewhere classified
31.4
9.5
12
*
QDA10
NOMESCO Finland
Incision of skin of lower limb
31.4
9.5
12
*
I79.2*E11.5
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic peripheral angiopathy
104.0
9.5
10
*
PG1AT
NOMESCO Finland
PTA of artery not elsewhere classified
104.0
9.5
10
*
PD3AT
NOMESCO Finland
Pelvic artery PTA
22.8
9.5
13
6
ZST00
NOMESCO Finland
Procedure related to previous procedure classified in chapter T
+∞
9.4
9
*
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
3.8
9.3
41
125
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
7.6
9.3
21
30
WX722
NOMESCO Finland
PEEP
6.0
9.2
25
46
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
9.6
9.2
18
20
SPAT1225
SPAT
Implementation of podiatry rehabilitation plan
16.4
9.1
14
9
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
2.4
9.1
112
646
V03AE02
ATC
sevelamer; oral
38.3
9.1
11
*
TPH07
NOMESCO Finland
Cathetrisation of artery
3.6
9.1
43
139
I74.3
ICD-10 Finland
Embolism and thrombosis of arteries of lower extremities
25.2
9.0
12
5
3AC01
NOMESCO Finland
NA
25.2
9.0
12
5
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
11.3
8.9
16
15
205
Kela drug reimbursment
Chronic hypertension
2.4
8.9
103
577
RS221
NOMESCO Finland
NA
14.8
8.8
14
10
PEN25
NOMESCO Finland
Plastic repair of superficial femoral artery
52.0
8.7
10
*
TK810
NOMESCO Finland
Hemofiltration
52.0
8.7
10
*
R53
ICD-10 Finland
Malaise and fatigue
2.8
8.6
59
247
L28
ICPC
Limited function/disability (L)
2.9
8.6
58
240
WNF00
NOMESCO Finland
Infection source and contact determination
93.2
8.5
9
*
L03.9
ICD-10 Finland
Cellulitis, unspecified
9.1
8.5
17
20
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
11.3
8.4
15
14
C08CA02
ATC
felodipine; oral
3.4
8.4
42
142
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
+∞
8.4
8
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.5
8.4
21
35
SPAT1151
SPAT
Treatment of major wounds
15.2
8.3
13
9
E10
ICD-10 Finland
Type 1 diabetes mellitus
15.2
8.3
13
9
A10AA02
ATC
NA
5.4
8.3
24
48
I10
ICD-10 Finland
Essential (primary) hypertension
2.3
8.3
159
1119
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
8.6
8.2
17
21
ZX120
NOMESCO Finland
Intravenous
3.6
8.2
37
115
RS220
NOMESCO Finland
NA
12.3
8.2
14
12
B01AB04
ATC
dalteparin; parenteral
4.9
8.2
26
58
Z49.2
ICD-10 Finland
Other dialysis
17.9
8.2
12
7
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
4.1
8.1
31
83
L17
ICPC
Foot/toe symptom/complaint
2.6
8.1
70
331
I20.00
ICD-10 Finland
Unstable angina
7.7
8.1
18
25
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
2.3
8.1
106
625
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
4.8
8.1
26
59
N02AJ06
ATC
codeine and paracetamol; systemic
2.4
8.0
83
435
H3603, E103
ICD-10 Finland
NA
13.7
8.0
13
10
I50.1
ICD-10 Finland
Left ventricular failure
5.0
8.0
25
55
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
2.5
8.0
72
353
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
4.7
7.8
26
61
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
19.1
7.7
11
6
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
19.1
7.7
11
6
R03BB04
ATC
tiotropium bromide; inhalant
3.8
7.6
32
94
J44.1
ICD-10 Finland
Chronic obstructive pulmonary disease with acute exacerbation, unspecified
6.4
7.6
19
32
R02
ICPC
Shortness of breath/dyspnoea
3.6
7.5
34
106
TQW40
NOMESCO Finland
Remowal of suture of skin
4.2
7.5
28
74
Z94.0
ICD-10 Finland
Kidney transplant status
14.0
7.5
12
9
AB18W
NOMESCO Finland
NA
82.6
7.5
8
*
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
5.8
7.4
20
37
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
6.2
7.4
19
33
RJ420
NOMESCO Finland
NA
11.4
7.4
13
12
J45.9
ICD-10 Finland
Asthma, unspecified
3.1
7.3
41
149
NH3DG
NOMESCO Finland
Very extensive MRI of foot
+∞
7.3
7
*
Z89.4
ICD-10 Finland
Acquired absence of foot and ankle
+∞
7.3
7
*
C02AC05
ATC
moxonidine; oral
4.9
7.3
23
51
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
2.4
7.3
70
351
WX210
NOMESCO Finland
Plexus blockade of nervus ichiadicus
16.4
7.3
11
7
A10BH05
ATC
linagliptin; oral
4.3
7.3
26
66
C09AA02
ATC
enalapril; systemic
2.4
7.2
73
375
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
31.0
7.2
9
*
XP60W
NOMESCO Finland
NA
31.0
7.2
9
*
XPX00
NOMESCO Finland
Intraoperative angiography
31.0
7.2
9
*
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
31.0
7.2
9
*
I48
ICD-10 Finland
Atrial fibrillation and flutter
2.3
7.1
76
400
ZXA10
NOMESCO Finland
Bilateral
2.5
7.0
58
269
X59
ICD-10 Finland
Exposure to unspecified factor
2.7
7.0
50
213
137
Kela drug reimbursment
Uraemia requiring dialysis
14.3
7.0
11
8
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
4.1
6.9
26
69
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
5.6
6.9
19
36
R4120
NOMESCO Finland
Occupational therapy
4.2
6.9
25
64
C02CA01
ATC
prazosin; oral
8.7
6.9
14
17
N06AX11
ATC
mirtazapine; oral
2.3
6.9
75
398
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
3.2
6.9
36
126
B01AB10
ATC
tinzaparin; parenteral
3.9
6.9
27
75
I21.41
ICD-10 Finland
Acute subendocardial infarction stenosed coronary artery
5.2
6.8
20
41
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
3.7
6.8
29
86
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
3.7
6.8
29
86
QDG99
NOMESCO Finland
Other operation for chronic ulcer or fistula of skin of lower limb
41.3
6.8
8
*
A10AA01
ATC
NA
6.8
6.8
16
25
T89
ICPC
Diabetes insulin dependent
5.8
6.8
18
33
PEF25
NOMESCO Finland
Thrombendarterectomy of superficial femoral artery
23.3
6.7
9
*
NG4AA
NOMESCO Finland
Lower leg X-ray examination
8.2
6.7
14
18
T90
ICPC
Diabetes non-insulin dependent
2.3
6.7
72
381
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
4.8
6.7
21
47
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
3.2
6.7
35
123
J01CA04
ATC
amoxicillin; systemic
2.1
6.7
169
1278
B03XA01
ATC
erythropoietin; parenteral
12.7
6.6
11
9
127
Kela drug reimbursment
Transplant complication
12.7
6.6
11
9
H04AA01
ATC
glucagon; nasal, parenteral
9.1
6.6
13
15
WX402
NOMESCO Finland
General anaesthesia
2.9
6.6
41
160
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.7
6.6
47
200
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.9
6.5
26
73
R33
ICD-10 Finland
Retention of urine
2.9
6.5
40
153
JN4BD
NOMESCO Finland
Extensive body CT
2.8
6.5
44
181
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
2.3
6.5
67
346
CKC12
NOMESCO Finland
Photocoagulation of retina
4.9
6.5
20
44
NFQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of hip or femur
71.7
6.5
7
*
GD1LA
NOMESCO Finland
GD
14.8
6.5
10
7
H02AB06
ATC
prednisolone; systemic
2.0
6.4
107
679
L84
ICD-10 Finland
Corns and callosities
6.9
6.4
15
23
I20.99
ICD-10 Finland
Angina pectoris, unspecified
3.9
6.4
25
69
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
3.9
6.4
25
69
K92
ICPC
Atherosclerosis/periph vascular dis
8.5
6.4
13
16
CKC10
NOMESCO Finland
Local photocoagulation of retina
8.5
6.4
13
16
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.4
6.4
22
54
A02BC05
ATC
esomeprazole; systemic
2.1
6.4
88
517
H02AB07
ATC
prednisone; oral
2.7
6.3
44
185
JN3AD
NOMESCO Finland
Abdominal CT examination
3.9
6.3
25
70
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
18.6
6.3
9
5
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
2.5
6.3
55
260
196
Kela drug reimbursment
Paricalcitol and cinacalcet
27.5
6.3
8
*
PEN24
NOMESCO Finland
Plastic repair of deep femoral artery
27.5
6.3
8
*
V03AE03
ATC
lanthanum carbonate; oral
27.5
6.3
8
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
6.0
6.3
16
28
E0000UV
ATC
NA
2.1
6.3
89
530
SPAT1254
SPAT
Administration of medicine
2.6
6.2
46
201
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.1
6.2
87
515
E87.5
ICD-10 Finland
Hyperkalaemia
9.0
6.1
12
14
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
2.1
6.1
80
458
L04AA06
ATC
mycophenolic acid; systemic
10.4
6.1
11
11
NE1AA
NOMESCO Finland
Pelvis X-ray examination
3.6
6.1
26
78
J01AA02
ATC
doxycycline; systemic
2.0
6.0
170
1313
C08CA13
ATC
lercanidipine; oral
2.7
6.0
41
169
WX110
NOMESCO Finland
Local anesthesy
2.0
6.0
142
1022
C09AA05
ATC
ramipril; oral
2.2
6.0
76
426
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007853) Bacteria identified in Skin by Aerobe culture
136
225
11.40
89.04
4.9
1.6
—
—
—
0
0
(3042936) Bacteria identified in Isolate by Culture
128
273
8.16
64.35
6.1
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
62
59
13.43
59.10
3.7
2.1
u/ml
0.3
0.4
1.22
36
31
(3000991) Gas panel - Venous blood
82
144
7.81
48.11
15.6
8.2
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
83
149
7.67
47.68
10.0
2.9
mmol/l
0.4
1.7
1.42
72
99
(3012544) pH of Venous blood
82
157
7.13
44.05
10.0
2.9
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
46
51
10.71
38.93
7.4
2.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
111
324
5.19
36.98
3.8
2.0
s
31.4
29.9
1.23
106
312
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
35
29
13.76
35.74
1.9
1.1
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
35
29
13.76
35.74
1.9
1.1
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
63
117
6.76
34.32
10.0
8.9
%
92.9
94.6
1.27
63
117
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
75
166
5.91
34.07
3.1
2.0
ug/l
3.6
8.8
2.05
69
141
(3022948) Iron [Moles/volume] in Serum or Plasma
103
301
4.97
33.87
5.8
2.5
umol/l
7.8
12.9
13.77
98
277
(3004789) Transferrin [Mass/volume] in Serum or Plasma
97
274
5.02
33.18
6.0
2.5
g/l
2.0
2.3
3.49
91
250
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
64
129
6.23
31.97
2.7
1.4
—
—
—
0
0
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
93
265
4.87
31.26
6.4
2.5
%
16.4
22.8
5.70
87
222
(3024928) Oxygen saturation in Venous blood
30
25
13.41
30.39
7.6
1.9
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
144
586
4.21
29.77
12.4
3.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
121
442
4.21
28.97
8.7
6.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
81
219
4.89
28.83
4.6
3.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
124
469
4.10
28.11
7.6
2.3
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
80
222
4.74
27.45
8.8
6.8
kpa
11.7
12.6
0.72
75
210
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
80
222
4.74
27.45
8.8
6.8
kpa
5.1
5.0
0.25
75
210
(3003458) Phosphate [Moles/volume] in Serum or Plasma
86
254
4.54
27.23
16.1
4.9
mmol/l
1.2
1.0
5.91
80
230
(3003396) Base excess in Arterial blood by calculation
79
221
4.67
26.77
8.7
6.8
mmol/l
0.6
1.2
0.65
68
171
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
78
232
4.35
24.19
2.5
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
20
12
17.95
23.97
7.5
1.7
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
77
236
4.19
22.82
2.5
1.6
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
94
332
3.84
22.79
6.9
3.2
ng/l
194.5
416.4
1.06
86
290
(3051611) Lipemic interference index of Serum or Plasma
24
22
11.90
22.76
8.0
2.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
119
493
3.57
22.60
2.9
2.0
mg/l
3.5
3.0
1.32
105
429
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
45
89
5.89
22.57
2.1
1.8
g/l
1.9
1.6
0.87
38
76
(3002173) Hemoglobin [Mass/volume] in Arterial blood
67
190
4.39
21.96
9.7
7.5
g/l
108.3
118.6
3.87
67
178
(3024891) Influenza virus A+B Ag [Presence] in Specimen
25
28
9.76
20.64
1.7
1.1
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
133
626
3.27
19.97
9.3
2.4
—
—
—
0
0
(36304419) Bacteria [Presence] in Urine
121
539
3.30
19.93
5.8
3.0
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
56
150
4.47
19.63
2.2
2.2
u/l
38.2
30.9
0.29
51
123
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
26
33
8.63
19.50
2.0
1.2
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
85
308
3.60
19.46
2.3
1.6
mg/l
1.4
1.4
0.03
70
250
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
90
339
3.51
19.39
4.6
2.7
e6/l
1.2
1.3
0.04
59
201
(3018418) pH of Serum or Plasma
128
599
3.21
19.25
11.6
3.7
ph
7.4
7.4
—
9
109
(3032080) INR in Blood by Coagulation assay
161
862
3.22
19.13
18.6
9.4
inr
1.3
1.4
0.20
22
233
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
88
333
3.46
18.75
4.9
2.9
e6/l
2.8
1.9
0.35
57
199
(3027945) Reticulocytes/100 erythrocytes in Blood
74
254
3.66
18.28
2.6
2.4
%
2.0
1.8
1.60
68
228
(3001122) Ferritin [Mass/volume] in Serum or Plasma
143
729
3.10
18.27
6.0
2.6
ug/l
168.0
166.5
0.03
133
659
(3030467) Casts [#/volume] in Urine by Automated count
122
572
3.11
18.02
5.8
3.0
e6/l
0.8
0.4
0.51
100
426
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
33
60
6.14
17.92
1.4
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
58
173
4.01
17.51
3.4
2.7
g/l
64.0
66.9
1.58
52
158
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
86
338
3.29
17.04
2.7
1.7
—
—
—
0
0
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
38
83
5.18
16.95
1.8
2.1
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
81
311
3.31
16.63
3.9
2.9
mmol/l
0.8
0.8
0.43
74
293
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
141
749
2.89
16.14
6.0
3.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
38
87
4.93
16.03
1.9
1.4
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
51
148
4.03
15.91
2.7
1.5
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
127
642
2.88
15.91
4.1
3.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
63
214
3.55
15.62
2.6
1.6
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
27
46
6.42
15.59
1.1
1.2
—
—
—
0
0
(3019198) Lymphocytes [#/volume] in Blood
156
888
2.85
15.44
10.5
5.1
e9/l
1.7
2.0
1.24
148
769
(3026782) Osmolality of Urine
96
424
2.99
15.33
3.9
2.6
mosm/kgh2o
531.0
575.8
1.57
79
360
(3000850) Epithelial cells [#/volume] in Urine
97
437
2.93
14.87
3.7
2.5
e6/l
5.7
4.7
0.22
86
378
(3002582) Erythrocytes [#/volume] in Urine
125
645
2.78
14.80
5.8
3.2
e6/l
59.8
81.4
0.41
104
489
(3001604) Monocytes [#/volume] in Blood
152
867
2.78
14.77
10.3
4.9
e9/l
0.7
0.6
2.95
143
723
(3006315) Basophils [#/volume] in Blood
152
867
2.78
14.77
10.4
5.0
e9/l
0.0
0.0
0.56
143
732
(3013115) Eosinophils [#/volume] in Blood
154
893
2.74
14.35
10.9
5.1
e9/l
0.2
0.2
0.50
146
766
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
155
909
2.71
14.00
8.8
4.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
39
102
4.31
13.91
11.1
10.6
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
73
291
3.09
13.81
41.4
26.3
inr
1.9
1.4
—
5
39
(3004588) Protein electrophoresis panel - Serum or Plasma
47
142
3.81
13.77
3.0
2.7
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
54
181
3.49
13.55
2.5
1.5
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
132
730
2.62
13.22
6.9
3.7
e6/l
73.9
115.0
0.88
102
525
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
40
111
4.07
13.17
1.9
1.4
—
—
—
0
0
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
161
981
2.64
13.16
18.2
6.0
mmol/l
1.2
1.2
7.84
148
814
(3019309) Folate [Moles/volume] in Red Blood Cells
93
433
2.77
13.16
1.8
1.8
nmol/l
1209.6
1189.0
0.06
76
329
(3013650) Neutrophils [#/volume] in Blood by Automated count
164
1015
2.63
12.87
13.7
8.7
e9/l
5.4
4.4
5.27
151
885
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
151
903
2.57
12.67
17.4
5.3
mmol/l
1.2
1.2
6.97
143
797
(42870588) Differential panel, method unspecified - Blood
113
594
2.58
12.39
9.9
5.1
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
97
474
2.65
12.35
3.9
2.8
umol/l
2768.4
10327.3
1.34
87
409
(3011397) Hemoglobin [Presence] in Urine by Test strip
87
405
2.71
12.18
6.1
4.0
—
—
—
0
0
(3019230) Fractional oxyhemoglobin in Venous blood
18
27
7.08
11.62
10.6
1.0
%
63.9
60.4
0.20
18
27
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
15
18
8.78
11.60
1.6
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
15
18
8.78
11.60
1.7
1.1
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
137
822
2.39
10.89
14.5
8.7
e9/l
0.0
0.0
0.47
116
671
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
14
17
8.64
10.71
2.9
3.1
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
44
151
3.30
10.52
13.5
3.6
ng/l
165.1
81.7
3.34
44
130
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
21
42
5.35
10.23
1.8
1.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
24
55
4.70
10.02
1.4
1.2
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
24
56
4.61
9.81
1.4
1.2
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
24
56
4.61
9.81
1.4
1.2
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
22
48
4.91
9.72
4.1
5.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
14
20
7.34
9.38
1.9
1.1
—
—
—
0
0
(3031040) Bacteria [#/volume] in Urine by Automated count
183
1301
2.33
9.10
8.0
4.4
—
5033.2
—
0
36
(3028308) Erythrocytes [#/volume] in Pleural fluid
15
25
6.30
8.75
1.9
1.2
e6/l
89472.4
29272.0
—
7
15
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
106
617
2.20
8.54
2.5
2.1
u/l
135.3
339.0
2.54
101
578
(3023199) Leukocytes [#/volume] in Pleural fluid
15
26
6.06
8.42
1.9
1.2
e6/l
1315.3
1819.5
—
7
19
(3015377) Calcium [Moles/volume] in Serum or Plasma
113
679
2.16
8.36
3.6
3.5
mmol/l
2.3
2.4
1.59
97
579
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
108
640
2.16
8.26
3.8
2.6
ng/l
6004.8
1473.6
3.21
94
547
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
22
55
4.27
8.25
2.0
1.5
—
—
—
0
0
(3020891) Body temperature
24
67
3.84
7.77
6.8
3.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
37
137
2.98
7.73
2.5
1.5
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
78
418
2.23
7.57
3.3
3.2
mmol/l
2.5
2.5
3.26
69
365
(3018405) Lactate [Moles/volume] in Arterial blood
24
69
3.73
7.46
4.6
2.7
mmol/l
1.2
1.4
0.49
24
69
(3023520) Reticulocytes [#/volume] in Blood
44
183
2.69
7.42
2.6
2.6
e9/l
78.5
65.4
1.86
30
143
(3019060) Gas panel - Arterial blood
33
118
3.05
7.32
4.1
4.3
—
—
—
0
0
(3015736) pH of Urine
112
699
2.05
7.26
5.5
3.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
22
61
3.84
7.19
5.0
2.8
mmol/l
4.1
4.1
0.15
22
56
(3037522) Nuclear Ab [Titer] in Serum
46
200
2.57
7.09
1.3
1.3
titre
855.0
448.1
—
8
54
(3025941) Bacteria identified in Stool by Culture
27
88
3.30
6.96
1.6
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
21
58
3.85
6.90
1.8
3.0
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
24
73
3.52
6.88
1.4
1.3
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
46
205
2.51
6.72
2.1
2.7
umol/l
5.7
9.8
1.33
41
186
(40768797) Stomach Pathology biopsy report
49
226
2.43
6.66
1.2
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
12
22
5.67
6.35
2.2
3.5
—
—
—
0
0
(3044889) 12 lead EKG panel
180
1366
2.00
6.33
5.5
3.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
141
994
1.90
6.10
7.9
6.3
umol/l
10.2
13.0
2.18
135
937
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
126
860
1.89
5.99
2.8
2.0
pmol/l
87.8
92.7
0.78
79
452
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
14
32
4.56
5.84
2.2
1.3
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
201
1615
2.02
5.63
72.2
15.5
%
35.4
38.9
6.94
147
1056
(3035320) C reactive protein [Mass/volume] in Body fluid
9
7
13.25
5.62
3.6
1.3
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
187
1472
1.93
5.49
12.8
7.2
u/l
94.5
80.8
2.15
180
1357
(3000494) Fungus identified in Specimen by Culture
43
208
2.27
5.21
1.7
1.4
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
92
592
1.85
5.09
4.4
3.3
mg/l
155.7
343.8
0.55
77
386
(3011648) Oxygen content in Venous blood
9
9
10.30
5.06
1.2
1.0
%
9.5
10.3
—
9
9
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
34
150
2.45
5.05
4.4
2.7
ml/min/173m2
51.5
59.6
0.57
19
60
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
14
37
3.94
4.88
1.3
1.5
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
12
28
4.44
4.88
1.8
1.9
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
8
7
11.73
4.81
1.9
1.9
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
28
584
0.42
4.76
2.7
3.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
12
29
4.29
4.68
1.5
1.7
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
12
29
4.29
4.68
1.1
1.1
—
49.4
—
0
5
(3021788) Differential panel - Synovial fluid
10
21
4.91
4.57
1.4
1.4
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
187
1520
1.79
4.40
73.9
17.5
%
15.1
13.8
12.34
182
1486
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
7
6
11.93
4.30
4.1
1.0
u/ml
1346.1
512.5
—
7
6
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
84
552
1.77
4.21
3.3
3.3
u/l
47.8
33.9
0.39
79
530
(3021960) Folate [Moles/volume] in Serum or Plasma
79
510
1.78
4.21
2.2
1.6
nmol/l
16.9
20.3
1.54
71
424
(3020682) Albumin/Creatinine [Ratio] in Urine
93
634
1.72
4.08
5.1
3.9
mg/mmol
34.0
8.0
1.89
69
403
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
14
43
3.38
3.96
1.5
1.3
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
89
606
1.71
3.89
4.5
3.1
mmol/l
5.5
7.6
6.55
76
483
(3037467) Urinalysis macro (dipstick) panel - Urine
167
1340
1.67
3.86
7.4
3.8
—
—
—
0
0
(3014891) Appearance of Pleural fluid
6
5
12.23
3.78
1.0
1.2
—
—
—
0
0
(3035350) Ketones [Presence] in Urine by Test strip
124
929
1.63
3.72
5.6
3.8
estimate
0.0
0.0
0.00
15
190
(3021601) Nitrite [Presence] in Urine by Test strip
123
925
1.62
3.60
7.6
5.1
estimate
0.0
0.0
0.00
15
188
(3008152) Bicarbonate [Moles/volume] in Arterial blood
27
126
2.27
3.56
8.1
5.6
mmol/l
24.2
23.8
0.19
27
114
(3009261) Glucose [Presence] in Urine by Test strip
124
938
1.61
3.52
5.7
3.8
estimate
0.0
0.0
0.00
13
185
(36660697) Celiac disease serology panel - Serum
22
94
2.46
3.52
1.1
1.2
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
15
53
2.94
3.42
3.9
1.9
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
10
7.15
3.38
1.1
1.5
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
6
7
8.73
3.28
1.7
1.1
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
10
28
3.67
3.23
1.7
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
7
11
6.50
3.20
1.0
1.2
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
215
1884
1.76
3.20
66.0
13.8
mg/l
35.0
29.2
2.43
207
1511
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
13
44
3.06
3.18
1.5
1.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
12
39
3.18
3.13
1.0
1.1
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
100
735
1.58
3.12
3.3
2.1
nmol/l
75.6
77.3
0.22
84
631
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
10
29
3.54
3.08
1.0
1.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
7
12
5.96
3.04
2.1
2.3
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
7
13
5.50
2.89
1.0
2.5
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
6
9
6.79
2.88
1.2
1.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
5
6
8.46
2.76
1.2
1.2
—
—
—
0
0
(3035880) pH of Pleural fluid
7
14
5.10
2.74
1.6
1.1
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
7
14
5.10
2.74
2.1
1.8
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
9
24
3.84
2.69
1.3
3.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
18
80
2.34
2.67
3.3
2.3
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
7
15
4.76
2.61
1.3
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
11
38
2.98
2.61
1.5
1.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
161
1349
1.50
2.57
5.4
3.7
mm/h
30.9
13.8
10.96
149
1206
(3024263) Appearance of Synovial fluid
5
8
6.34
2.38
1.2
1.5
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
7
17
4.20
2.37
3.6
2.3
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
59
409
1.57
2.29
7.5
4.5
kg/l
1.0
1.0
—
6
52
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
6
13
4.70
2.28
1.0
1.2
—
—
—
0
0
(4062490)
6
13
4.70
2.28
1.0
1.5
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
7
19
3.75
2.16
1.9
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
7
19
3.75
2.16
1.3
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
10
5.07
2.08
1.8
1.3
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
10
5.07
2.08
1.8
1.3
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
97
760
1.44
2.07
7.0
3.1
ng/l
88.8
52.0
0.96
74
567
(3000093) Morphology [Interpretation] in Blood Narrative
7
20
3.57
2.07
1.3
1.2
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
7
20
3.57
2.07
1.9
1.2
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
7
20
3.57
2.07
1.9
1.2
—
—
—
0
0
(4010399)
21
112
1.95
2.03
1.3
1.3
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
78
589
1.46
2.02
3.6
2.3
u/l
49.1
56.4
1.31
72
529
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
38
245
1.64
1.98
1.3
1.2
iu/ml
17.9
29.5
0.61
12
81
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
154
1317
1.41
1.97
3.6
3.5
pmol/l
15.1
15.1
0.05
135
1151
(3007164) IgA [Mass/volume] in Serum or Plasma
44
295
1.59
1.97
2.0
1.3
g/l
3.1
2.8
0.21
25
172
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
6
16
3.81
1.94
1.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
13
59
2.27
1.87
2.2
2.3
ug/min
48.3
138.1
—
7
31
(40761535) Cells panel - Urine sediment
27
161
1.75
1.87
6.5
3.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
5
12
4.22
1.83
1.6
1.2
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
5
12
4.22
1.83
1.6
1.2
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
7
23
3.10
1.81
1.9
1.2
—
—
—
0
0
(3013512) EKG study
41
585
0.65
1.81
5.0
3.6
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
6
18
3.39
1.75
1.5
1.2
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
35
229
1.61
1.74
1.3
1.2
u/ml
14.1
10.6
—
8
86
(3001019) Free T4 and TSH panel - Serum or Plasma
0
48
0.00
1.71
0.0
2.1
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
6
19
3.21
1.67
2.0
1.2
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
6
19
3.21
1.67
2.0
1.2
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
6
19
3.21
1.67
2.0
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
11
49
2.30
1.66
1.8
1.4
—
—
—
0
0
(44790047)
5
14
3.62
1.62
1.6
1.5
—
—
—
0
0
(44806118)
5
14
3.62
1.62
1.6
1.5
—
—
—
0
0
(44790049)
5
14
3.62
1.62
1.6
1.5
—
—
—
0
0
(44790048)
5
14
3.62
1.62
1.6
1.5
—
—
—
0
0
(3000492) Spirometry study
21
122
1.78
1.60
1.6
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
9
37
2.48
1.49
1.9
1.9
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
88
712
1.35
1.48
2.3
2.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
9
38
2.42
1.47
1.8
1.4
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
7
28
2.54
1.46
1.0
1.1
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
9
39
2.35
1.44
1.9
1.4
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
7
150
0.45
1.36
2.0
2.5
nmol/l
6.3
13.1
—
7
128
(44816559) Phosphatidylethanol [Mass/volume] in Blood
6
24
2.53
1.31
2.0
1.3
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
10
48
2.13
1.29
1.5
1.7
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
40
530
0.71
1.18
4.1
3.3
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
215
2012
1.37
1.18
71.9
16.6
mmol/l
138.4
139.6
7.56
205
1942
(40761511) CBC panel - Blood by Automated count
211
1971
1.35
1.16
51.0
13.3
—
—
—
0
0
(21494434) Karyotype in Bone marrow
5
20
2.53
1.15
1.2
1.2
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
7
30
2.37
1.13
1.9
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
36
264
1.42
1.09
29.4
7.1
—
—
—
0
0
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
7
32
2.22
1.09
1.0
1.1
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
215
2020
1.35
1.08
73.2
16.7
mmol/l
4.1
4.0
4.51
205
1953
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
105
905
1.27
1.07
3.9
2.4
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
10
53
1.92
1.02
2.2
2.1
umol/l
37.3
35.4
—
10
43
(3019225) pH of Specimen
12
198
0.59
1.00
10.0
3.8
—
—
—
0
0
(3022621) pH of Urine by Test strip
8
142
0.55
0.96
2.0
3.2
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
83
966
0.79
0.96
3.4
5.4
ug/l
2.7
3.2
0.26
65
847
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
41
320
1.33
0.88
1.5
1.2
u/ml
1.1
1.1
—
7
86
(3003694) ABO and Rh group [Type] in Blood
63
524
1.27
0.85
1.3
1.3
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
8
47
1.72
0.81
1.1
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
0
24
0.00
0.79
0.0
2.1
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
177
1661
1.20
0.68
4.8
4.3
mu/l
2.1
2.0
0.44
158
1457
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
5
28
1.80
0.66
3.2
3.8
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
5
28
1.80
0.66
2.0
1.2
pmol/l
64.4
427.3
—
5
28
(3019832) Treponema pallidum Ab [Presence] in Serum
14
95
1.50
0.65
1.9
1.4
—
—
—
0
0
(3002256) Pathology report gross observation
33
262
1.30
0.65
1.3
1.3
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
43
354
1.26
0.64
4.8
4.5
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
0
21
0.00
0.60
0.0
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
184
1744
1.18
0.58
4.9
4.0
mmol/l
1.4
1.3
1.19
169
1547
(40761536) Microorganisms panel - Urine sediment
12
172
0.68
0.58
5.9
3.4
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
6
35
1.73
0.58
1.8
2.0
—
—
—
0
0
(1616796) Gas panel - Central venous blood
6
36
1.68
0.57
4.0
3.7
—
—
—
0
0
(3022313) Gas panel - Capillary blood
13
90
1.47
0.56
6.8
2.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
49
571
0.83
0.55
2.0
3.1
ug/l
1.0
0.8
0.16
30
403
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
121
1114
1.16
0.55
3.8
2.9
u/l
71.4
57.9
0.71
109
1014
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
22
172
1.30
0.50
1.8
1.9
%
1.7
1.6
0.16
17
145
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
177
1850
0.87
0.47
4.9
4.6
mmol/l
7.2
6.1
4.65
150
1633
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
188
1803
1.15
0.44
5.2
4.4
mmol/l
1.2
1.4
9.29
173
1613
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
15
0.00
0.41
0.0
3.1
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
0
17
0.00
0.41
0.0
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
185
1777
1.14
0.40
10.1
6.1
mmol/mol
50.8
40.8
11.50
178
1616
(3035637) Corticotropin [Mass/volume] in Plasma
0
18
0.00
0.40
0.0
1.2
—
—
—
0
0
(40768443) Skin Pathology biopsy report
11
80
1.39
0.39
1.3
1.3
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
5
36
1.40
0.38
2.2
1.9
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
216
2100
1.16
0.37
83.0
20.5
e12/l
4.0
4.4
20.45
209
2022
(3007461) Platelets [#/volume] in Blood
216
2100
1.16
0.37
82.8
20.5
e9/l
271.0
241.3
4.64
209
2028
(3010813) Leukocytes [#/volume] in Blood
216
2100
1.16
0.37
83.1
20.6
e9/l
8.2
6.9
11.14
209
2024
(3013139) Helicobacter pylori Ag [Presence] in Stool
11
81
1.37
0.37
1.1
1.2
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
207
2008
1.14
0.36
18.6
9.9
u/l
31.6
24.5
0.39
202
1909
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
51
455
1.15
0.35
1.8
1.8
pmol/l
477.5
430.6
0.35
41
370
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
70
762
0.89
0.33
3.5
4.6
%
19.5
20.8
0.35
25
398
(3020564) Creatinine [Moles/volume] in Serum or Plasma
208
2024
1.13
0.32
65.0
17.1
umol/l
123.0
82.7
6.25
208
2024
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
8
106
0.75
0.29
1.1
1.7
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
8
110
0.72
0.29
1.5
3.7
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
8
63
1.28
0.28
1.4
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
5
75
0.66
0.26
1.2
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
82
0.73
0.24
1.3
2.0
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
78
735
1.09
0.22
6.9
4.1
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
187
1824
1.09
0.22
5.3
4.4
mmol/l
3.9
4.5
12.79
179
1652
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
3.7
—
197.0
—
0
11
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
0
11
0.00
0.21
0.0
1.1
—
1.9
—
0
11
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(4024509)
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
0
10
0.00
0.21
0.0
2.2
—
—
—
0
0
(4211845)
0
10
0.00
0.21
0.0
4.6
—
—
—
0
0
(44806420)
0
10
0.00
0.21
0.0
2.0
—
—
—
0
0
(3037556) Urate [Mass/volume] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
0
13
0.00
0.21
0.0
1.0
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(40768441) Liver Pathology biopsy report
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
11
91
1.22
0.18
2.5
2.9
—
—
—
0
0
(4034850)
5
67
0.74
0.17
10.8
9.4
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
9
79
1.14
0.15
2.2
1.5
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
191
1876
1.07
0.15
6.1
4.9
mmol/l
2.1
2.6
14.63
179
1679
(3029937) Albumin [Presence] in Urine by Test strip
57
542
1.07
0.13
8.4
3.9
estimate
0.0
0.0
0.00
14
181
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
50
474
1.07
0.12
2.0
1.6
mmol/l
1.5
1.3
0.43
42
384
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
10
86
1.17
0.11
2.8
1.7
—
—
—
0
0
(3022145) Colonoscopy Study observation
21
193
1.10
0.10
1.5
1.3
—
—
—
0
0
(4035726)
18
166
1.09
0.08
1.4
1.4
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
15
141
1.07
0.03
1.3
1.4
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
10
94
1.07
0.01
2.0
1.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
11
104
1.06
0.01
1.9
1.8
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
16
166
0.96
0.00
2.1
1.7
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
20
202
0.99
0.00
1.4
1.5
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
10
103
0.97
0.00
2.3
2.4
—
22.7
—
0
6
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
178
1785
0.99
0.00
56.5
13.5
ml/min/173m2
66.4
75.4
3.65
164
1456
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
0
7
0.00
0.00
0.0
1.0
—
405.4
—
0
7
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
1.1
—
0
9
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
5.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(4015189)
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
0
8
0.00
0.00
0.0
4.3
—
49.6
—
0
8
(3010503) CD19 cells [#/volume] in Blood
0
6
0.00
0.00
0.0
1.5
—
0.2
—
0
6
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
0
6
0.00
0.00
0.0
1.8
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011544) Albumin [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.0
—
19.9
—
0
6
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
5
54
0.92
0.00
4.8
6.8
mmol/l
1.7
1.3
—
5
43
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
2317.8
—
0
5
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
2.8
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3024666) Lithium, Blood [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
11.4
—
0.7
—
0
5
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.5
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
0
8
0.00
0.00
0.0
5.5
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
7
76
0.92
0.00
3.7
5.1
%
0.5
0.9
—
7
67
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
7
76
0.92
0.00
3.7
5.1
%
2.7
1.5
—
7
67
(1761482) Bacteria [#/volume] in Urine by Culture
6
65
0.92
0.00
1.8
4.2
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: R18_GANGRENE_NOT_ELSEW_CLASSIFIED – Gangrene, not elsewhere classified
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).